LOGIN EMAIL
PASSWORD
|
|
CRO / CMO Reports
Dashboard
Custom Reporting Capabilities
Quarterly Intelligence Process
Survey Development Process
Help / FAQs
Titles of Survey Respondents
CRO / CMO Industry Trends
Leading CRO / CMO Companies
NI Company News
NI Media Clippings
NI Published Articles
NI Calendar of Events
NI Product Upgrades
NI Media Partners
NI Industry Partners & Associations
CMO Leadership Awards
Company Profile
Key Personnel
Company A-Z
Company by Markets
Company by Sectors
Company by Regions
Top Publicly Traded Companies
3M Drug Delivery Systems regulatory score, which speaks to the company’s track record on compliance, increased by 6%.
GlaxoSmithKline Biopharmaceuticals affordability score, which speaks to the company’s ability to price projects within sponsor budgets, increased by 5%.
Pfizer CentreSource's quality score, which speaks to the company’s ability to deliver high specifications in terms of quality, increased by 4%.
AAIPharma's productivity score, which speaks to the company’s ability to deliver on agreed objectives while the project sponsor focuses on their core competencies, increased by 8%.
Fisher BioServices productivity score, which speaks to the company’s ability to deliver on agreed objectives while the project sponsor focuses on their core competencies, increased by 8%.
Therapure Biopharma's affordability score, which speaks to the company’s ability to price projects within sponsor budgets, increased by 3%.
Pharmaceutical Manufacturing Research Services quality score, which speaks to the company’s ability to deliver high specifications in terms of quality, increased by 2%.
CMC Biologics affordability score, which speaks to the company’s ability to price projects within sponsor budgets, increased by 7%.
Norwich Pharmaceuticals regulatory score, which speaks to the company’s track record on compliance, increased by 9%.
Piramal Healthcare Pharma Solutions reliability score, which speaks to the ability of the company to meet all project milestones and timelines, increased by 3%.
Covance's quality score, which speaks to the company’s ability to deliver high specifications in terms of quality, increased by 3%.
Charles River Laboratories International's reliability score, which speaks to the ability of the company to meet all project milestones and timelines, increased by 6%.
P. J. Noyes Company's affordability score, which speaks to the company’s ability to price projects within sponsor budgets, increased by 12%.
Nelson Laboratories regulatory score, which speaks to the company’s track record on compliance, increased by 5%.
Wolfe Laboratories productivity score, which speaks to the company’s ability to deliver on agreed objectives while the project sponsor focuses on their core competencies, increased by 4%.
Pharmaceutical Product Development's reliability score, which speaks to the ability of the company to meet all project milestones and timelines, increased by 3%.
PharmaNet's regulatory score, which speaks to the company’s track record on compliance, increased by 9%.
Toxikon Corporation's affordability score, which speaks to the company’s ability to price projects within sponsor budgets, increased by 9%.
Diteba Research Laboratories quality score, which speaks to the company’s ability to deliver high specifications in terms of quality, increased by 3%.
Particle Technology Labs reliability score, which speaks to the ability of the company to meet all project milestones and timelines, increased by 7%.
Abbott Contract Manufacturing's reliability score, which speaks to the ability of the company to meet all project milestones and timelines, increased by 2%.
Advion's affordability score, which speaks to the company’s ability to price projects within sponsor budgets, increased by 3%.
Agilent Technologies affordability score, which speaks to the company’s ability to price projects within sponsor budgets, increased by 3%.
Albany Molecular Research's reliability score, which speaks to the ability of the company to meet all project milestones and timelines, increased by 10%.
Alturas Analytics,'s quality score, which speaks to the company’s ability to deliver high specifications in terms of quality, increased by 7%.
Analytical Bio-Chemistry Laboratories affordability score, which speaks to the company’s ability to price projects within sponsor budgets, increased by 6%.
Ash Stevens productivity score, which speaks to the company’s ability to deliver on agreed objectives while the project sponsor focuses on their core competencies, increased by 8%.
BASi (Bioanalytical Systems, Inc.)'s reliability score, which speaks to the ability of the company to meet all project milestones and timelines, increased by 1%.
BioVectra's reliability score, which speaks to the ability of the company to meet all project milestones and timelines, increased by 9%.
Cambridge Major Laboratories quality score, which speaks to the company’s ability to deliver high specifications in terms of quality, increased by 9%.
Cook Pharmica's affordability score, which speaks to the company’s ability to price projects within sponsor budgets, increased by 8%.
Critical Path Services affordability score, which speaks to the company’s ability to price projects within sponsor budgets, increased by 1%.
Dottikon Exclusive Synthesis reliability score, which speaks to the ability of the company to meet all project milestones and timelines, increased by 4%.
Hospira One 2 One's quality score, which speaks to the company’s ability to deliver high specifications in terms of quality, increased by 3%.
Huntingdon Life Sciences regulatory score, which speaks to the company’s track record on compliance, increased by 8%.
ICON plc's regulatory score, which speaks to the company’s track record on compliance, increased by 3%.
Intertek Group plc's reliability score, which speaks to the ability of the company to meet all project milestones and timelines, increased by 1%.
Jubilant HollisterStier Contract Manufacturing & Services productivity score, which speaks to the company’s ability to deliver on agreed objectives while the project sponsor focuses on their core competencies, increased by 4%.
Lonza's reliability score, which speaks to the ability of the company to meet all project milestones and timelines, increased by 8%.
Metrics regulatory score, which speaks to the company’s track record on compliance, increased by 6%.
MPI Research's quality score, which speaks to the company’s ability to deliver high specifications in terms of quality, increased by 4%.
Oso BioPharmaceuticals Manufacturing's quality score, which speaks to the company’s ability to deliver high specifications in terms of quality, increased by 4%.
Paragon Bioservices affordability score, which speaks to the company’s ability to price projects within sponsor budgets, increased by 2%.
Pharmatek Laboratories reliability score, which speaks to the ability of the company to meet all project milestones and timelines, increased by 1%.
Product Safety Labs productivity score, which speaks to the company’s ability to deliver on agreed objectives while the project sponsor focuses on their core competencies, increased by 1%.
Recipharm AB's quality score, which speaks to the company’s ability to deliver high specifications in terms of quality, increased by 6%.
Ricerca Biosciences productivity score, which speaks to the company’s ability to deliver on agreed objectives while the project sponsor focuses on their core competencies, increased by 5%.
Seventh Wave Laboratories regulatory score, which speaks to the company’s track record on compliance, increased by 3%.
Siegfried Group's affordability score, which speaks to the company’s ability to price projects within sponsor budgets, increased by 2%.
Spaulding Clinical Research's regulatory score, which speaks to the company’s track record on compliance, increased by 2%.
Tandem Labs quality score, which speaks to the company’s ability to deliver high specifications in terms of quality, increased by 5%.
Vetter Pharma International GmbH's affordability score, which speaks to the company’s ability to price projects within sponsor budgets, increased by 1%.
Thermo Scientific's regulatory score, which speaks to the company’s track record on compliance, increased by 6%.
Xcelience's productivity score, which speaks to the company’s ability to deliver on agreed objectives while the project sponsor focuses on their core competencies, increased by 4%.
GenScript's affordability score, which speaks to the company’s ability to price projects within sponsor budgets, increased by 5%.
Microbac Laboratories reliability score, which speaks to the ability of the company to meet all project milestones and timelines, increased by 2%.
PCI Synthesis’s reliability score, which speaks to the ability of the company to meet all project milestones and timelines, increased by 4%.
Solvay Organics reliability score, which speaks to the ability of the company to meet all project milestones and timelines, increased by 5%.
Akorn’s quality score, which speaks to the company’s ability to deliver high specifications in terms of quality, increased by 6%.
Alkermes affordability score, which speaks to the company’s ability to price projects within sponsor budgets, increased by 3%.
Bioagri Laboratories productivity score, which speaks to the company’s ability to deliver on agreed objectives while the project sponsor focuses on their core competencies, increased by 11%.
Blue Sky Biotech’s quality score, which speaks to the company’s ability to deliver high specifications in terms of quality, increased by 4%.
Cirion's affordability score, which speaks to the company’s ability to price projects within sponsor budgets, increased by 5%.
Confab Laboratories productivity score, which speaks to the company’s ability to deliver on agreed objectives while the project sponsor focuses on their core competencies, increased by 5%.
Corden Pharma Colorado’s regulatory score, which speaks to the company’s track record on compliance, increased by 75%.
CoreRx’s reliability score, which speaks to the ability of the company to meet all project milestones and timelines, increased by 13%.
Ei Solution Works quality score, which speaks to the company’s ability to deliver high specifications in terms of quality, increased by 2%.
Eurofins Lancaster Laboratories quality score, which speaks to the company’s ability to deliver high specifications in terms of quality, increased by 7%.
ExxPharma’s quality score, which speaks to the company’s ability to deliver high specifications in terms of quality, increased by 6%.
All Markets
CMO
Biomanufacturing
Small Molecules
CRO
Biologics
Small Molecules
All Regions
Americas
Europe
Asia
All Sectors
Bioanalytical Services
Blending
Chemical Synthesis
Clinical Research
Consulting Projects
Custom Manufacturing
Cytotoxic
Data Management
Drug Delivery Systems
Drug Metabolism
Environmental Testing
Fill and Finish
High Potency Compounds
Hygiene Testing
Intellectual Property
Logistics and Distribution
Lyophilization
Packaging
PEGs
Pharma Analytical Services
Pre-Formulation & Formulation
Process Optimization
Product Characterization
Regulatory Support
Stability Storage and Testing
Sterile
Toxicology
Company Website
Life science leader
Outsourcing Insights
Life science leader
The Story Behind Outsourcing Insights & Bio Data Points
pharmaceutical COmmerce
Bringing order to the outsourced manufacturing space
INVESTORS.COM
Nice Insight Launches Its Q1 CRAMS Report
BIOSPACE
Nice Insight Launches Q1 Pharma & Biotech Outsourcing Survey
Jubilant HollisterStier Contract Manufacturing & Services productivity score, which speaks to the company’s ability to deliver on agreed objectives while the project sponsor focuses on their core competencies, increased by 4%.
Albany Molecular Research's reliability score, which speaks to the ability of the company to meet all project milestones and timelines, increased by 10%.
Intertek Group plc's reliability score, which speaks to the ability of the company to meet all project milestones and timelines, increased by 1%.
May 18
Nice Insight partners with Generic Pharma 2.0
May 17
Nice Insight partners with Pharmaceutical Outsourcing magazine
May 16
Nice Insight to launch quarterly trends email
View details
2012 Q1
European Respondent Group
Learn more
2012 Q1
Dashboard
Learn more
Process Optimization: Innovation's Role
04.18.2012
Nice Insight is featured in Pharmaceutical Processing in an article that discusses the role of innovation in the outsourcing of Process Optimization.
Read the article
2012 AAPS National Biotechnology Conference
May 21-23 San Diego, CA
ILSI - BioMed 2012
May 21-23 Tel Aviv, Israel
BIO 2012
Set up a meeting with us at BIO 2012
InformEx
BioProcess International Europe
DIA
Bio International Convention
AAPS
CPhI Worldwide
Understand the capture power of an advertisement - and whether viewers are taking away the intended message. Click to view larger.
1
of 4
Q1 2012 Update
GenScript
COMPANY INDEX
Company A-Z
Company by Markets
Company by Segments
Company by Regions
Top Publicly Traded Companies
MARKETS
PRODUCTS
CRO / CMO Reports
Dashboard
Custom Reporting Capabilities
PROCESS
Quarterly Intelligence Process
Survey Development Process
Help / FAQs
MEDIA CENTER
CRO / CMO Industry Trends
Leading CRO / CMO Companies
NI Company News
NI Media Clippings
NI Published Articles
NI Calendar of Events
NI Product Upgrades
NI Media Partners
Leadership Awards
COMPANY
Company Profile
Key Personnel
LOG IN
CONTACT US
That's Nice LLC
6 West 20th Street
Second Floor
New York, NY 10011-9270
USA
Telephone
The information in this website is intended for research
purposes and is therefore subject to change. Nice Insight
herein takes no responsibility for information that may be
inaccurate. Data was gathered from Nice Insight's Q4
Pharmaceutical and Biotechnology Outsourcing survey,
conducted in November 2011.
CONNECT
New York
San Diego
London
Frankfurt
Shanghai
Shenzhen